News coverage about Atrion (NASDAQ:ATRI) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Atrion earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 46.7913709832887 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the headlines that may have effected Accern Sentiment’s scoring:
Separately, BidaskClub lowered Atrion from a “sell” rating to a “strong sell” rating in a research note on Monday, December 18th.
Shares of Atrion (ATRI) opened at $597.10 on Wednesday. Atrion has a 52 week low of $459.05 and a 52 week high of $694.00. The firm has a market capitalization of $1,077.96, a PE ratio of 30.29 and a beta of 0.70.
Atrion (NASDAQ:ATRI) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $4.66 earnings per share for the quarter. Atrion had a return on equity of 19.53% and a net margin of 24.96%. The business had revenue of $34.02 million for the quarter.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 15th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Wednesday, March 14th. This represents a $4.80 dividend on an annualized basis and a dividend yield of 0.80%. Atrion’s payout ratio is 24.35%.
Atrion Company Profile
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.